Amneal Pharmaceuticals, Inc. AMRX Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s total cost of revenue?
- Amneal Pharmaceuticals, Inc. (AMRX) reported total cost of revenue of $402.41M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s total cost of revenue changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s total cost of revenue decreased by 8.4% year-over-year, from $439.53M to $402.41M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s total cost of revenue has grown at a 9.5% compound annual growth rate (CAGR), from $1.32B to $1.91B.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.